England - London • Corporate and commercial

DLA Piper

We only have limited information for this firm. Consider the following firms which have provided more information:

Benefitting from a heightened focus within the venture space in recent years, including - for the first time in the UK - a discrete internal emerging companies offering, DLA Piper continues to gain traction in the market for an investor focused client base within the tech and life sciences sectors, in particular. The firm is best-suited to handling Series A investments through to exit, although it does also handle some earlier stage work for many of its corporate venture clients, which are an important constituent of its investor client base, alongside institutional investors. Team head Luca Gori has ‘deep expertise in venture capital transactions’, particularly in the fintech and insurtech space, where as well as advising on purely domestic mandates, he is also adept at handling cross-border mandates, where he is able to draw from resources throughout the firm’s global network of offices. Senior associate Dylan Kennett has ’an indefatigable work ethic’, which he effectively deploys for the firm’s core investor client base, as well as some investees.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • 'They are willing to jump on any engagement right away, dive right into what is important, and are quick to find the right commercial solution.'
  • 'They have a hands-on approach and bring real deal expertise to the table.'

Abbreviated data is displayed for this firm.

Key clients

  • Aviva Ventures
  • Avalon Bay Communities Inc

Abbreviated data is displayed for this firm.

Work highlights

  • Advised a consortium of investors (including Pfizer Ventures, Cambridge Innovation Capital, M Ventures, Taiho Ventures LLC, Seroba Life Sciences, and IP Group) on a $30m Series B investment in Storm Therapeutics Limited.
  • Advised SoftBank Vision 2 Fund on their $50m investment (as lead investor) in Improbable MV Limited as part of a wider $150m round.

Abbreviated data is displayed for this firm.